HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 298 filers reported holding HAEMONETICS CORP in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $6,539,000 | -43.3% | 100,315 | -45.0% | 0.03% | -47.7% |
| Q1 2022 | $11,537,000 | +243.0% | 182,485 | +187.7% | 0.06% | +261.1% |
| Q4 2021 | $3,364,000 | -57.8% | 63,429 | -43.8% | 0.02% | -64.7% |
| Q3 2021 | $7,972,000 | -42.2% | 112,930 | -45.4% | 0.05% | -46.9% |
| Q2 2021 | $13,796,000 | +253.5% | 207,020 | +488.8% | 0.10% | +231.0% |
| Q1 2021 | $3,903,000 | -33.8% | 35,159 | -48.0% | 0.03% | -40.8% |
| Q3 2020 | $5,897,000 | -32.2% | 67,585 | -30.4% | 0.05% | -50.5% |
| Q2 2020 | $8,701,000 | +210.3% | 97,157 | +298.1% | 0.10% | +80.0% |
| Q4 2019 | $2,804,000 | -0.2% | 24,403 | +9.5% | 0.06% | +12.2% |
| Q3 2019 | $2,811,000 | +30.2% | 22,288 | -9.7% | 0.05% | -24.6% |
| Q1 2019 | $2,159,000 | -10.3% | 24,683 | -8.1% | 0.06% | 0.0% |
| Q2 2018 | $2,408,000 | +135.4% | 26,855 | +52.5% | 0.06% | +195.5% |
| Q4 2017 | $1,023,000 | – | 17,608 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |